Submit Deal

Submit Deal

Cover Image Kate Haviland

Kate Haviland

CEO at BLUEPRINT MEDICINES

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 1.03 B

Avg. Deal Size£ 1.03 B

Market Context

Sort

30 Jun 2022|United States|Biotechnology

Target: BLUEPRINT MEDICINES

Bidder: SIXTH STREET PARTNERS

6 Service Providers

3 Target | 3 Bidder

7 Dealmakers

3 Target | 4 Bidder

£ 1.03 B

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite